Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/308% above fair value
$26.95+0.37 (+1.39%)
Close on Nov 13, 2026Market cap $3.53BP/E –Yield –
Surgery Partners EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Surgery Partners's EV/EBITDA was 15.1× on Nov 11, 2026, against 12.5× a year earlier. Over the last 5 years it ranged from 11.4× to 21.9×, with a median of 15.3×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 15.1× | +2.9 |
| 2025 | Dec 31, 2025 | 12.2× | −2.4 |
| 2024 | Dec 31, 2024 | 14.5× | −2.6 |
| 2023 | Dec 29, 2023 | 17.1× | +3.4 |
| 2022 | Dec 30, 2022 | 13.7× | −6.3 |
| 2021 | Dec 31, 2021 | 20.0× | +1.7 |
| 2020 | Dec 31, 2020 | 18.3× | −2.1 |
| 2019 | Dec 31, 2019 | 20.4× | +5.5 |
| 2018 | Feb 28, 2018 | 14.8× | +0.9 |
| 2017 | Dec 29, 2017 | 14.0× | +1.0 |
| 2016 | Dec 30, 2016 | 13.0× | −2.4 |
| 2015 | Dec 31, 2015 | 15.3× | – |
See a number that looks wrong?